The HP-GPC data for healthy humans has been pubCardiovascular Research 1996;32:909-919 were inadverlished in Circulation 1994;90:129-140 with a typical HPtently the plotted values for high performance-gel permea-GPC plot of healthy human plasma and urine also in tion chromatography (HP-GPC) of healthy humans rather Peptides 1994;15:861-867. than the plotted values of rat congestive heart failure The authors deeply regret sending the wrong figures and plasma as shown in the overleaf.
Figs. 7 and 8 of the article by Poulos et al. in
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apologize for any confusion caused by this oversight. Fig. 7 . High-performance gel-permeation chromatography followed by plasma of rats with congestive heart failure as determined by highvessel dilator (i.e., proANF 31-67) radioimmunoassay of each 0.3 ml performance gel-permeation chromatography (HP-GPC). One distinct fraction obtained from plasma of rats with congestive heart failure peak in plasma consisting of 0.3 ml fractions 74-79 with the peak in revealed that vessel dilator exists in plasma as a distinct peptide. The fraction 77 was found with HP-GPC evaluation followed by atrial elution of vessel dilator from plasma was identical with the pure synthetic natriuretic peptide radioinimunoassay. This peak in plasma was identical form of vessel dilator (arrow). V 5total volume of column; V 5void 
